Description
E2A-PBX1; TEL-AML1; MLL-AF4; MLL-ENL; MLL-AF9; BCR-ABL1 (Major,Minor/Micro)
Acute Lymphoblastic Leukemia (ALL) Panel by PCR
E2A-PBX1; TEL-AML1; MLL-AF4; MLL-ENL; MLL-AF9; BCR-ABL1 (Major,Minor/Micro)
TAT: 7 working days
Specimen Type: Blood/Bone marrow aspirate in K2 EDTA (Purple cap tubes)
Molecular Biology Panel Test
Other Tests
-
238%
CLPD panel-1 CD5,,CD23,CD19,CD3,CD10,CD79b,CD38,CD200, Kappa, Lambda
Kappa,Lamda,CD38,19,45,5,10,20,3,4,5,7,56,200,23,43,49d,FMC-7, Additiional CD103,123,25,11c
CLPD panel-1 CD5,,CD23,CD19,CD3,CD10,CD79b,CD38,CD200, Kappa, Lambda
Kappa,Lamda,CD38,19,45,5,10,20,3,4,5,7,56,200,23,43,49d,FMC-7, Additiional CD103,123,25,11c
-
240%
Complete Pneumonia Panel
Bacteria semiqunatitative, atypical bacteria, viruses and anti microbial resistance qualitative
Complete Pneumonia Panel
Bacteria semiqunatitative, atypical bacteria, viruses and anti microbial resistance qualitative
-
137%
AML Panel by PCR
PML RARA; AML ETO; CBFB-MYH11; BCR-ABL1 (Major, Minor); C-KIT; NMP1; FLT3-ITD; FLT3-TKD
AML Panel by PCR
PML RARA; AML ETO; CBFB-MYH11; BCR-ABL1 (Major, Minor); C-KIT; NMP1; FLT3-ITD; FLT3-TKD
- 249%
Reviews
There are no reviews yet.